China Pharma Holdings, Inc.
CPHI
$1.50
-$0.0634-4.06%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.53% | 22.27% | -50.44% | 22.42% | -58.46% |
| Total Depreciation and Amortization | -35.70% | -5.74% | 0.75% | 5.46% | 1.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -124.17% | -87.88% | 20,095.24% | -800.00% | -90.32% |
| Change in Net Operating Assets | 217.89% | 56.69% | 157.12% | -170.26% | -53.24% |
| Cash from Operations | 607.45% | 35.35% | 87.58% | -2,524.22% | -102.21% |
| Capital Expenditure | -311.96% | 132.74% | -- | -- | 35.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3,066.30% | 132.74% | -- | -- | 93.33% |
| Total Debt Issued | 0.00% | -98.64% | 7,140.58% | -99.35% | 5,368.81% |
| Total Debt Repaid | -- | 100.00% | -- | -- | -126.63% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -1.45% | 0.00% | -77.30% | 106.38% |
| Foreign Exchange rate Adjustments | -729.41% | 282.14% | 16.42% | -113.29% | 1,020.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -345.63% | 79.30% | 82.99% | -1,183.33% | -88.46% |